ko stock fundamentals - cash flow
Cash Flow
- capital Expenditures --276,000,000
- cash Change 14,295,000,000
- cash Flow 160,000,000
- cash Flow Financing 2,065,000,000
- changes In Inventories 4,727,000,000
- changes In Receivables 4,599,000,000
- currency USD
- depreciation 286,000,000
- filing Type 10-Q
- fiscal Date 2023-03-31
- fiscal Quarter 1
- fiscal Year 2023
- fiscal Year 2023
- net Borrowings 24,846,000,000
- net Income 3,107,000,000
- report Date 2023-04-26
- symbol KO
- total Investing Cash Flows 117,000,000
- id CASH_FLOW
- key KO
- subkey quarterly
- date 2023-03-31
- updated 2023-05-04
Related News

Novo Nordisk Stock VS. AstraZeneca - NVO Climbs Toward $135 With $25B Obesity Franchise While AZN Trails at $73.53
TradingNEWS Archive
26.09.25

AstraZeneca Stock price Forecast - AZN at $73: Oncology and Farxiga Deliver Billions While Valuation Compresses
TradingNEWS Archive
25.09.25